Mumps vaccine effectiveness in highly immunized populations

Vaccine

Volumn 28, Issue 20, 2010, Pages 3567-3570

  Domínguez, Angela ^a,b   Torner, Núria ^b,c   Castilla, Jesús ^b,d   Batalla, Joan ^b,c   Godoy, Pere ^b,c   Guevara, Marcela ^b,d   Carnicer, Dolors ^b,e   Caylà, Joan ^b,e   Rius, Cristina ^b,e   Jansà, Josep Maria ^b,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c Generalitat of Catalonia ^*  (Spain)

^d INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^e AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

Author keywords

Immunization; Mumps; Vaccine effectiveness

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; MUMPS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; COMMUNITY; DRUG EFFICACY; EPIDEMIC; HUMAN; IMMUNIZATION; INFANT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MUMPS; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SCHOOL CHILD; SCREENING; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; HUMANS; INFANT; MUMPS; MUMPS VACCINE; SPAIN; YOUNG ADULT;

EID: 77950692225     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.02.107     Document Type: Article

References (43)

1. Carbone K.M., and Rubin S. Mumps virus. In: Knipe D.M. (Ed). Fields virology. 5th ed. (2007), Wolters Kluwer, Philadelphia 1527-1550
2. Plotkin S.A., and Rubin S.A. Mumps vaccine. In: Plotkin S.A., Orenstein W., and Offit O. (Eds). Vaccines. 5th ed. (2008), Elsevier, Philadelphia 435-465
3. American Academy of Pediatrics. Mumps. In: Pickering L.K., Baker C.J., Kimberlin D.W., and Long S.S. (Eds). Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. (2009), American Academy of Pediatrics, Elk Grove Village, Ill 468-472
4. Conly J., and Johnston B. Is mumps making a comeback?. Can J Infect Dis Med Microbiol 18 1 (2007) 7-9
5. Hilleman M.R., Weibel R.E., Buynak E.B., Stokes Jr. J., and Whitman Jr. J.E. Live attenuated mumps-virus vaccine. IV. Protective efficacy as measured in a field evaluation. N Engl J Med 276 5 (1967) 252-258
6. Sugg W.C., Finger J.A., Levine R.H., and Pagano J.S. Field evaluation of live virus mumps vaccine. J Pediatr 72 4 (1968) 461-466
7. Centers for Disease Control and Prevention. Recommendations of the international task force for disease eradication. MMWR Morb Mortal Wkly Rep 1993 [cited 2008 September 15]. Available from: URL: http://www.cdc.gov/.
8. Peltola H., Davidkin I., Paunio M., Valle M., Leinikki P., and Heinonen O.P. Mumps and rubella eliminated from Finland. J Am Med Assoc 284 20 (2000) 2643-2647
9. Pugh R.N., Akinosi B., Pooransingh S., Kumar J., Grant S., Livesley E., et al. An outbreak of mumps in the metropolitan area of Walsall, UK. Int J Infect Dis 6 4 (2002) 283-287
10. Cohen C., White J.M., Savage E.J., Glynn J.R., Choi Y., Andrews N., et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis 13 1 (2007) 12-17
11. Centers for Disease Control, Prevention. Mumps outbreak at a summer camp - New York, 2005. MMWR Morb Mortal Wkly Rep 55 7 (2006) 175-177
12. Ong G., Goh K.T., Ma S., and Chew S.K. Comparative efficacy of Rubini, Jeryl-Lynn and Urabe mumps vaccine in an Asian population. J Infect 51 4 (2005) 294-298
13. Goncalves G., De A.A., and Monteiro Cardoso M.L. Outbreak of mumps associated with poor vaccine efficacy - Oporto Portugal 1996. Euro Surveill 3 12 (1998) 119-121
14. Germann D., Strohle A., Eggenberger K., Steiner C.A., and Matter L. An outbreak of mumps in a population partially vaccinated with the Rubini strain. Scand J Infect Dis 28 3 (1996) 235-238
15. Cardeñosa N., Dominguez A., Camps N., Martínez A., Torner N., Navas E., et al. Non-preventable mumps outbreaks in schoolchildren in Catalonia. Scand J Infect Dis 38 8 (2006) 671-674
16. Peña-Rey I., Tello O., Martinez M.V., Alcalde E., and Castellanos M.T. Epidemiologia del sarampión en España. In: Dominguez A., and Borras E. (Eds). El Sarampion (2008), Sociedad Española de Epidemiologia, Madrid 125-154
17. Castilla J., Garcia C.M., Barricarte A., Irisarri F., Nuñez-Cordoba J.M., and Barricarte A. Mumps outbreak in Navarre region, Spain, 2006-2007. Euro Surveill 12 2 (2007) E070215
18. Instituto Nacional de Estadística (INE). Movimiento natural de la población. http://www ine.es/inebmenu/mnu_mnp htm [cited 2008 Oct 2]. Available from: URL: www.ine.es; 2008.
19. Farrington C.P. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol 22 4 (1993) 742-746
20. Kleinbaum D.G., Kupper L.L., and Morgenstern H. Epidemiologic research: principles and quantitative methods (1982), Van Nostrand Reinhold, New York
21. Guy R.J., Andrews R.M., Kelly H.A., Leydon J.A., Riddell M.A., Lambert S.B., et al. Mumps and rubella: a year of enhanced surveillance and laboratory testing. Epidemiol Infect 132 3 (2004) 391-398
22. Peltola H., Kulkarni P.S., Kapre S.V., Paunio M., Jadhav S.S., and Dhere R.M. Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Clin Infect Dis 45 4 (2007) 459-466
23. Harling R., White J.M., Ramsay M.E., Macsween K.F., and van den Bosch C. The effectiveness of the mumps component of the MMR vaccine: a case control study. Vaccine 23 31 (2005) 4070-4074
24. Schaffzin J.K., Pollock L., Schulte C., Henry K., Dayan G., Blog D., et al. Effectiveness of previous mumps vaccination during a summer camp outbreak. Pediatrics 120 4 (2007) e862-e868
25. Castilla J., Garcia C.M., Arriazu M., Fernandez-Alonso M., Martinez-Artola V., Etxeberria J., et al. Effectiveness of Jeryl Lynn-containing vaccine in Spanish children. Vaccine 27 15 (2009) 2089-2093
26. Montes M., Cilla G., Artieda J., Vicente D., and Basterretxea M. Mumps outbreak in vaccinated children in Gipuzkoa (Basque Country), Spain. Epidemiol Infect 129 3 (2002) 551-556
27. de Ory F., Sanz J.C., and Garcia-Bermejo I. The triple virus vaccine: old viruses, new problems. Enferm Infecc Microbiol Clin 25 4 (2007) 227-229
28. Kaaijk P., van der Zeijst B., Boog M., and Hoitink C. Increased mumps incidence in the Netherlands: review on the possible role of vaccine strain and genotype. Euro Surveill 13 26 (2008)
29. Jin L., Beard S., and Brown D.W. Genetic heterogeneity of mumps virus in the United Kingdom: identification of two new genotypes. J Infect Dis 180 3 (1999) 829-833
30. Shanley J.D. The resurgence of mumps in young adults and adolescents. Cleve Clin J Med 74 1 (2007) 42-48
31. Centers for Disease Control, Prevention. Mumps epidemic - Iowa, 2006. MMWR Morb Mortal Wkly Rep 55 13 (2006) 366-368
32. Boga J.A., de Oña M., Fernandez-Verdugo A., Gonzalez D., Morilla A., Arias M., et al. Molecular identification of two genotypes of mumps virus causing two regional outbreaks in Asturias, Spain. J Clin Virol 42 4 (2008) 425-428
33. Litman N., and Baum S.G. Mumps virus. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Principles and practice of infectious diseases. 17th ed. (2009), Churchill Livingstone, Philadelphia 2201-2206
34. Rubin S.A., Qi L., Audet S.A., Carbone K.M., Bellini W.J., Rota P.A., et al. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. J Infect Dis 198 4 (2008) 508-515
35. Borrs E., Domínguez A., Batalla J., Torner N., Cardenosa N., Nebot M., et al. Vaccination coverage in indigenous and immigrant children under 3 years of age in Catalonia (Spain). Vaccine 25 16 (2007) 3240-3243
36. Dayan G.H., Quinlisk M.P., Parker A.A., Barskey A.E., Harris M.L., Schwartz J.M., et al. Recent resurgence of mumps in the United States. N Engl J Med 358 15 (2008) 1580-1589
37. Vandermeulen C., Roelants M., Vermoere M., Roseeuw K., Goubau P., and Hoppenbrouwers K. Outbreak of mumps in a vaccinated child population: a question of vaccine failure? Vaccine 22 21-22 (2004) 2713-2716
38. Hamilton-West K. Factors influencing MMR vaccination decisions following a mumps outbreak on a university campus. Vaccine 24 24 (2006) 5183-5191
39. Anderson R.M., and May R.M. Immunisation and herd immunity. Lancet 335 8690 (1990) 641-645
40. Anderson R.M., and May R.M. Vaccination and herd immunity to infectious diseases. Nature 318 6044 (1985) 323-329
41. Date A.A., Kyaw M.H., Rue A.M., Klahn J., Obrecht L., Krohn T., et al. Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population. J Infect Dis 197 12 (2008) 1662-1668
42. Park D.W., Nam M.H., Kim J.Y., Kim H.J., Sohn J.W., Cho Y., et al. Mumps outbreak in a highly vaccinated school population: assessment of secondary vaccine failure using IgG avidity measurements. Vaccine 25 24 (2007) 4665-4670
43. Dayan G.H., and Rubin S. Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks?. Clin Infect Dis 47 11 (2008) 1458-1467